ProCE Banner Activity

CE / CME

A Focus on the Psychopharmacology of Pain Management and Opioid Use Disorder

Video

Watch this webcast recording of the presentation on pain management and opioid use disorder given in December 2023 at the CCO Psychopharmacology Update Conference. The thorough presentation covers pain diagnosis, strategies for developing an individualized treatment plan, the various nonpharmacologic and pharmacologic approaches to pain, and how to complete a risk assessment to mitigate opioid misuse. In addition, opioid use disorder identification and management are reviewed, including the importance of comprehensive management using both psychological and pharmacologic approaches.

Psychologists: 2.50 APA CE Credits

Social Workers: 2.50 ASWB ACE CE Credits

Nurses: 2.50 Nursing contact hours, including 2.50 hours of pharmacotherapy credit

Physician Assistants/Physician Associates: 2.50 AAPA Category 1 CME credits

Physicians: maximum of 2.50 AMA PRA Category 1 Credits

Pharmacists: 2.50 contact hours (0.25 CEUs)

Dental Professionals: 2.50 ADA CERP credits

Optometrists: 2.50 COPE CE credits 

Released: January 05, 2024

Expiration: October 31, 2024

Begin Activity

Share

Faculty

Samantha Catanzano

Samantha Catanzano, PharmD, BCPP

Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
Psychiatric Pharmacist
UT Health Austin, Dell Medical School
Austin, Texas

Jennifer Sorensen

Jennifer Sorensen, MSW, LSW, CPRS, CPS, DRCC

Social Worker

Dace Svikis

Dace Svikis, PhD

Professor
Department of Psychology
Virginia Commonwealth University
Richmond, Virginia

Michael Sprintz

Michael Sprintz, DO, DFASAM

Medical Consultant
Chronic Pain, Addiction, Healthcare Technology
Founder, Sprintz Center for Recovery
The Woodlands, Texas

Provided by

Provided by Clinical Care Options, LLC and in partnership with the Alliance to Advance Comprehensive Integrative Pain Management, American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.

ProCE Banner

Supporters

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see this link for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Opioid Analgesic REMS Program Companies

Partners

Alliance to Advance Comprehensive Integrative Pain Management

ProCE Banner

American Academy of Physical Medicine and Rehabilitation

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner

Target Audience

This program is designed to educate HCPs in the United States, particularly HCPs practicing in settings with multidisciplinary and interprofessional healthcare teams, including physicians, advanced practice nurses, physician associates, pharmacists, nurses, psychologists, social workers, dental professionals, and optometrists. Specialty areas include, but are not limited to, physiatry, psychiatry, neurology, family medicine, internal medicine, pain management, and surgery.

Program Learning Goal

The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Pain Management

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify fundamental concepts of pain management, including mechanisms of pain; risk factors for misuse, abuse, and opioid use disorder; and appropriate assessment of pain

  • Create an individualized, patient-specific pain treatment plan that safely and effectively integrates the range of therapeutic options, including initiating therapy, titrating, and discontinuing non-opioid medications and opioid analgesics

  • Design an individualized patient and caregiver education plan on the safe use, storage, and disposal of opioid analgesics and the role of reversal agents

  •  Construct a systematic approach to screening for and appropriately managing patients with opioid use disorder

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Program Director

Samantha Catanzano, PharmD, BCPP

Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
Psychiatric Pharmacist
UT Health Austin, Dell Medical School
Austin, Texas

Samantha Catanzano, PharmD, BCPP, has no relevant financial relationships to disclose.

Jennifer Sorensen, MSW, LSW, CPRS, CPS, DRCC

Social Worker

Jennifer Sorensen, MSW, LSW, CPRS, CPS, DRCC has no relevant financial relationships to disclose.

Dace Svikis, PhD

Professor
Department of Psychology
Virginia Commonwealth University
Richmond, Virginia

Dace Svikis, PhD, has no relevant financial relationships to disclose.

Presenter

Michael Sprintz, DO, DFASAM

Medical Consultant
Chronic Pain, Addiction, Healthcare Technology
Founder, Sprintz Center for Recovery
The Woodlands, Texas

Michael Sprintz, DO, DFASAM: consultant/advisor/speaker:  Saluda Medical, Spark Biomedical.

The planners and content peer reviewers from Clinical Care Options, LLC; the American Academy of Physical Medicine and Rehabilitation (AAPMR); the Alliance to Advance Comprehensive Integrative Pain Management; Practicing Clinicians Exchange; and ProCE, LLC do not have any relevant financial relationships to disclose, except Gabrielle Giacona, Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, Ameet Nagpal, MD, MS, MEd, MBA, and Amanda Zimmerman, PA-C, as noted below.

Gabrielle Giacona: individual publicly traded stocks/stock options: AstraZeneca, Moderna.

Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC: consultant/advisor/speaker: Salix.

Ameet Nagpal, MD, MS, MEd, MBA: consultant/advisor/speaker: Averitas; researcher: Saol Therapeutics.

Amanda Zimmerman, PA-C: consultant/advisor/speaker: Averitas, Collegium.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 2.5 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from January 05, 2024, through October 31, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page
  2. Read the target audience, learning objectives, and faculty disclosures
  3. View and study the content in its entirety
  4. Submit answers to the post-test questions and evaluation questions online

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 2.5 contact hours, including 2.5 hour of pharmacotherapy credits. 

Continuing Pharmacy Education

CCO designates this continuing education activity for 2.5 contact hours (0.25 CEUs) of the Accreditation Council for Pharmacy Education.

UAN: JA4008176-0000-24-049-H08-P 
Type of Activity: Application

Upon successfully completing the post-test with a score of 65 or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.5 AAPA Category 1 CME credits. Approval is valid until October 31, 2024. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity offers 2.5 continuing education credits for psychologists.

Social Work Continuing Education


As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 2.5 clinical continuing education credits.

Dental Professionals Continuing Education

 

Clinical Care Options, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP

Clinical Care Options, LLC designates this activity for 2.5 continuing education credits. 

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Optometrist Continuing Education
Clinical Care Options, LLC designates this asynchronous enduring activity for a maximum of 2.5 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.